MRI-guided radiotherapy for cancer treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study utilizes the MRI linac Unity, a cutting-edge technology that combines a linear accelerator with a 1.5T MRI to enhance the precision of radiotherapy. It aims to adapt daily radiation doses based on the tumor's position, volume, and response, while also characterizing the radiosensitivity of both healthy and tumor tissues through specific MRI sequences. By generating 3D maps of intra-tumor radiosensitivity, the study seeks to optimize treatment plans and improve patient outcomes. The research is observational and focuses on patients diagnosed with various types of cancer who are receiving external radiotherapy.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18years old or older
* diagnosed with prostate, kidney, cervix, head and neck cancer or glioblastoma
* indication of external radiotherapy
* treated with the Linac UNITY MRI guided radiotherapy at the centre hospitalier Lyon Sud des Hospices Civils de Lyon
* agreement of the patient to participate
* affiliated to a social security system

Exclusion Criteria:

patient unable to keep a lying position during all the procedure

* patient under law restriction
* pregnant women or breastfeeding

Where it's running

• Hôpital Lyon Sud/ service de Radiothérapie Oncologie
  Lyon, France Recruiting

Study contacts

• Study coordinator: Olivier CHAPET, MD
• Email: Olivier.chapet@chu-lyon.fr
• Phone: 4 78 86 42 51

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Virtual exercise program to preserve function and prevent disability during chemotherapy

  This trial tests whether supervised resistance sessions by video plus short home aerobic workouts help adults 18–64 maintain strength and stay active while receiving curative-intent chemotherapy.

  Recruiting at 29 sites Alliance for Clinical Trials in Oncology · Dublin, California and 29 other locations · NCT07059884

• Using brodalumab to treat immune-related side effects from cancer therapy

  This study is testing if brodalumab can help cancer patients who are having immune-related side effects from their immunotherapy treatment feel better.

  Recruiting Phase 1 Columbia University · New York, New York · NCT06673329

• Using Riluzole to Help Breast Cancer Survivors with Cognitive Issues

  This study is testing if the medication riluzole can help breast cancer survivors who are having trouble with thinking and memory feel better.

  Recruiting Phase 2 University of California, Irvine · Orange, California · NCT06580002

• Adaptive radiotherapy using a new linear accelerator for cancer treatment

  This study is testing a new way to adjust radiation therapy for cancer patients each day based on changes in their tumors to see if it improves treatment.

  Recruiting Charite University, Berlin, Germany · Berlin · NCT06116019

• A network for collaborative cancer research in Ontario

  This study is testing a new way to improve cancer treatment by using genetics and technology to help personalize care for people with different types of cancer.

  Recruiting at 2 sites University Health Network, Toronto · Kingston, Ontario and 2 other locations · NCT05403177

• Testing if lab drug screening can predict cancer treatment responses

  This study is testing if a new way of checking how tumors respond to different cancer treatments can help doctors choose the best options for patients with solid tumors like bladder or kidney cancer.

  Recruiting Sheffield Teaching Hospitals NHS Foundation Trust · Sheffield, South Yorkshire · NCT05231655

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.